blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2766370

EP2766370 - COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.06.2017
Database last updated on 11.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2014/34]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / LIANG, Chungen
Lane 825 Chenhui Road
Building 5, Room 1202
Pudong Shanghai, 201203 / CN
02 / WANG, Lisha
Lane 1950 Siping Road
No. 20, Room 101
Shanghai, 200433 / CN
03 / YUN, Hongying Yun
802 Yinghua Road
Building 1
Apartment 202
Pudong Shanghai, 201204 / CN
04 / ZHENG, Xiufang
Room 504, No. 2
Lane 1728 Chengshan Road
Shanghai, 200128 / CN
 [2014/34]
Representative(s)Zhuang Plodeck, Jianping
F. Hoffmann-La Roche AG
CLP - Patent Department
Grenzacherstrasse 124
675 / 3. OG
4070 Basel / CH
[N/P]
Former [2014/34]Zhuang Plodeck, Jianping
F. Hoffmann-La Roche AG CLP - Patent Department Grenzacherstrasse 124 675 / 3. OG
4070 Basel / CH
Application number, filing date12772299.908.10.2012
[2016/31]
WO2012EP69813
Priority number, dateWO2011CN8062711.10.2011         Original published format: PCT/CN2011/080627
[2014/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013053658
Date:18.04.2013
Language:EN
[2013/16]
Type: A1 Application with search report 
No.:EP2766370
Date:20.08.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.04.2013 takes the place of the publication of the European patent application.
[2014/34]
Type: B1 Patent specification 
No.:EP2766370
Date:03.08.2016
Language:EN
[2016/31]
Search report(s)International search report - published on:EP18.04.2013
ClassificationIPC:C07D495/04, A61K31/519, A61P31/12
[2014/34]
CPC:
C07D495/04 (EP,US); A61P31/12 (EP); A61P31/14 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/34]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERBINDUNGEN ZUR BEHANDLUNG UND PROPHYLAXE VON ERKRANKUNGEN DURCH DAS RESPIRATORISCHE SYNZYTIAL-VIRUS[2014/34]
English:COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE[2014/34]
French:COMPOSÉS DESTINÉS À TRAITER ET À PRÉVENIR LA MALADIE PROVOQUÉE PAR LE VIRUS RESPIRATOIRE SYNCYTIAL[2014/34]
Entry into regional phase12.05.2014National basic fee paid 
12.05.2014Designation fee(s) paid 
12.05.2014Examination fee paid 
Examination procedure12.05.2014Examination requested  [2014/34]
10.10.2014Amendment by applicant (claims and/or description)
18.02.2016Communication of intention to grant the patent
02.06.2016Fee for grant paid
02.06.2016Fee for publishing/printing paid
02.06.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.02.2016
Opposition(s)04.05.2017No opposition filed within time limit [2017/28]
Fees paidRenewal fee
07.10.2014Renewal fee patent year 03
07.10.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.10.2012
AL03.08.2016
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE08.10.2016
LU08.10.2016
MT31.10.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
[2018/46]
Former [2018/34]HU08.10.2012
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE08.10.2016
LU08.10.2016
MT31.10.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2018/31]HU08.10.2012
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE08.10.2016
LU08.10.2016
MT31.10.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2018/30]HU08.10.2012
AT03.08.2016
BE03.08.2016
CY03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
MC03.08.2016
MK03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE08.10.2016
LU08.10.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/51]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
IE08.10.2016
LU08.10.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/45]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
LU08.10.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/37]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SI03.08.2016
SK03.08.2016
SM03.08.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/23]AT03.08.2016
BE03.08.2016
CZ03.08.2016
DK03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SK03.08.2016
SM03.08.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/23]AT03.08.2016
BE03.08.2016
CZ03.08.2016
EE03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RO03.08.2016
RS03.08.2016
SE03.08.2016
SK03.08.2016
BG03.11.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/13]AT03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
LV03.08.2016
NL03.08.2016
PL03.08.2016
RS03.08.2016
SE03.08.2016
BE31.10.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/11]AT03.08.2016
FI03.08.2016
HR03.08.2016
LT03.08.2016
NL03.08.2016
PL03.08.2016
RS03.08.2016
SE03.08.2016
BE31.10.2016
NO03.11.2016
GR04.11.2016
IS03.12.2016
PT05.12.2016
Former [2017/10]FI03.08.2016
HR03.08.2016
LT03.08.2016
NL03.08.2016
PL03.08.2016
RS03.08.2016
SE03.08.2016
BE31.10.2016
NO03.11.2016
IS03.12.2016
Former [2017/09]FI03.08.2016
LT03.08.2016
NL03.08.2016
NO03.11.2016
Former [2017/07]LT03.08.2016
Cited inInternational search[A]US2002099208  (YU KUO-LONG [US], et al) [A] 1-15 * claim 1 *;
 [A]WO2005061513  (BIOTA SCIENT MANAGEMENT [AU], et al) [A] 1-15 * claim 1 *
by applicant   - WANDSTRAT TL, ANN PHARMACOTHER., (199701), vol. 31, no. 1, pages 83 - 8
    - PEDIATRICS., (199809), vol. 102, no. 3, pages 531 - 7
    - FELTES TF ET AL., J PEDIATR., (200310), vol. 143, no. 4, pages 532 - 40
    - DEVINCENZO J. ET AL., PROC NATL ACAD SCI U S A., (20100511), vol. 107, no. 19, pages 8800 - 5
    - ZAMORA MR ET AL., AM J RESPIR CRIT CARE MED., (20110215), vol. 183, no. 4, pages 531 - 8
    - BASTIN R.J., ORGANIC PROCESS RESEARCH & DEVELOPMENT, (2000), vol. 4, pages 427 - 435
    - ANSEL, H., Pharmaceutical Dosage Forms and Drug Delivery Systems, (1995), pages 196,1456 - 1457
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.